
Approaching MDS: Advances in Diagnostics, Therapeutics and Monitoring
From HemeTalks: Conversations in Hematology Education by American Society of Hematology
April 16, 2026 · 25 min · Season 5 · Episode 21
About this episode
This episode discusses advances in the diagnosis and management of myelodysplastic neoplasms with expert insights from Drs. DeZern and Mack.
Join us for an insightful discussion on myelodysplastic neoplasms (or MDS) with Drs. DeZern and Mack as we review the current standards in diagnosis of MDS using cutting edge molecular techniques. This marrow failure syndrome requires thoughtful and accurate diagnosis to ensure appropriate risk assessment for clinical decision making. We will then review relevant therapeutic choices and how to monitor on and off therapy through the case of a 68 yo male with a 6-year history of disease. We will explore key diagnostic considerations, the distinct testing required for prognostication and the therapies available in lower and high-risk disease. This episode offers practical, evidence-based insights to enhance the recognition and management of MDS. Learning Objectives: Understand accurate diagnostic testing needed in MDS including core and aspirate, iron stain, IHC, and molecular diagnostics (MK and NGS) Review limited therapeutic options currently available in MDS Discuss management strategies at each stage of this disease from lower risk to higher risk with suitable monitoring plans Clinical Pearls: Comprehensive diagnosis and reassessment during disease course guide best practices…
People in this episode
Guests: Dr. DeZern, Dr. Mack
Topics covered
- myelodysplastic neoplasms
- diagnostics
- therapeutics
- monitoring
- risk assessment
- case study
Keywords
- MDS
- diagnosis
- therapeutics
- monitoring
- molecular techniques
- risk assessment
- case study
- cytopenia
Mentioned in this episode
Organizations: American Society of Hematology
Books & works: myelodysplastic neoplasms, MDS
More episodes of HemeTalks: Conversations in Hematology Education
- Re‑Thinking “Normal”: Absolute Neutrophil Count by Duffy Status · June 4, 2026 · 21 min
- Multiple Myeloma Care: Timing, Teamwork, Treatment · May 21, 2026 · 23 min
- Atención del Mieloma Múltiple: Oportunidad, Trabajo en Equipo y Tratamiento · May 21, 2026 · 22 min
- TTP Today: Diagnosis, Management & Evolving Therapies · May 7, 2026 · 20 min
- New Horizons in Smoldering Multiple Myeloma · March 19, 2026 · 26 min
- Interpreting Abnormal SPEP – Is It Just MGUS? · February 19, 2026 · 27 min
Explore listener stats, chart rankings, contacts and more on the HemeTalks: Conversations in Hematology Education podcast page.